Tag: NASDAQ:CGIX
November 20, 2019
Cancer Genetics Reports Q3 Financial Results
Cancer Genetics has reported its Q3 strategic, financial and operating results for the third quarter ended September 30, 2019. August 20, 2019
Cancer Genetics Reports Q2 Financial Results
Cancer Genetics (NASDAQ:CGIX) has released its second quarter results for the quarter ended June 30, 2019. As quoted in the... January 29, 2019
Cancer Genetics Announces Pricing of $3.5 Million Public Offering of Common Stock
Cancer Genetics (Nasdaq:CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers and diagnostics, today... December 17, 2018
Cancer Genetics Terminates Proposed Merger with NovellusDx
Cancer Genetics (Nasdaq:CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers and diagnostics, today...
October 3, 2018
VIDEO — Life Science Update September 2018
With September officially behind us, the Investing News Network is taking a look back at some of the biggest news...
September 18, 2018
Cancer Genetics Merges with NovellusDx
Two companies with similar oncology goals, Cancer Genetics and NovellusDx, have signed a definitive merger agreement, announced Tuesday. September 18, 2018
